Omega Fund Management, LLC
Source: SEC Form 13F · as of Mar 2026Omega Fund Management, LLC holds 9 biotech & pharma companies tracked by BioSniper, totaling $157.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
9
Total value held
$157.2M
BioSniper AIPage evidence connected
Prepared research question
What matters most for Bicara Therapeutics Inc. (BCAX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| BCAXBicara Therapeutics Inc. | 2,392,150 | $47.6M |
| NUVBNuvation Bio Inc. | 8,081,089 | $34.7M |
| BBOTBridgeBio Oncology Therapeutics, Inc. | 3,289,661 | $29.4M |
| KMTSKestra Medical Technologies Ltd. | 1,022,149 | $20.4M |
| BBNXBeta Bionics Inc. | 1,316,183 | $13.2M |
| ALMSALUMIS INC. | 241,255 | $5.3M |
| SANASana Biotechnology, Inc. | 843,750 | $2.4M |
| IMAImageneBio, Inc. | 455,361 | $2.3M |
| REPLReplimune Group, Inc. | 248,672 | $1.9M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.